While performance hasn't been mind blowing so far, psychedelics are where cannabis was a decade or so ago.
I'm looking at a possible inverse head and shoulders forming on many cannabis charts.
Yet there's good relative strength in biotech, growth, cannabis, small-caps, and other sectors that have been the biggest laggards.
They range from doing nothing to jumping into the day-trading fray.
TLRY posted promising earnings, but don't expect it smoke past its current levels for long.
You think the Tilray brand name is worth $2.8B? Market cap is barely above $3B. Does give me pause.
Cannabis is about the only space where I'm long, and that isn't for technical reasons.
The broader market had a very tough go of it in 2021, but you wouldn't know it unless you do some digging. From Reddit and Diamond Hands to SPACs and a stealth bear market, it's been a wild ride.
And there are a few ETFs and a silver miner that could provide the vehicles to play this hunch.
Will these exchange-traded funds pay off or send your portfolio up in a 'PUF'?